0.400
-0.07 (-15.44%)
| Penutupan Terdahulu | 0.473 |
| Buka | 0.448 |
| Jumlah Dagangan | 413,330 |
| Purata Dagangan (3B) | 323,754 |
| Modal Pasaran | 17,643,022 |
| Harga / Jualan (P/S) | 0.170 |
| Harga / Buku (P/B) | 0.260 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 5 May 2025 - 9 May 2025 |
| Margin Keuntungan | -13.18% |
| Margin Operasi (TTM) | 1.87% |
| EPS Cair (TTM) | -0.280 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -12.80% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 70.25% |
| Nisbah Semasa (MRQ) | 0.820 |
| Aliran Tunai Operasi (OCF TTM) | 1.44 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 4.93 M |
| Pulangan Atas Aset (ROA TTM) | -2.23% |
| Pulangan Atas Ekuiti (ROE TTM) | -18.19% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Instruments & Supplies (US) | Menurun | Bercampur |
| Medical Instruments & Supplies (Global) | Menurun | Menurun | |
| Stok | Harvard Bioscience, Inc. | Menurun | Menurun |
AISkor Stockmoo
| Konsensus Penganalisis | 1.5 |
| Aktiviti Orang Dalam | 1.5 |
| Volatiliti Harga | 0.5 |
| Purata Bergerak Teknikal | 1.0 |
| Osilator Teknikal | -0.5 |
| Purata | 0.80 |
|
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, Multichannel Systems MCS GmbH, and Panlab.. The majority of its revenue comes from the United States. |
|
| Sektor | Healthcare |
| Industri | Medical Instruments & Supplies |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 7.99% |
| % Dimiliki oleh Institusi | 76.21% |
| Julat 52 Minggu | ||
| Median | 3.00 (649.44%) | |
| Jumlah | 1 Tidak Dinilai | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Benchmark | 13 May 2025 | 3.00 (649.44%) | Tidak Dinilai | 0.370 |
| 24 Mar 2025 | 4.50 (1,024.16%) | Tidak Dinilai | 0.600 |
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 12 May 2025 | Pengumuman | Harvard Bioscience Announces First Quarter 2025 Financial Results |
| 05 May 2025 | Pengumuman | Harvard Bioscience Schedules First Quarter 2025 Earnings Conference Call for May 12, 2025 at 8:00 AM ET |
| 10 Apr 2025 | Pengumuman | Harvard Bioscience Announces CFO Transition |
| 12 Mar 2025 | Pengumuman | Harvard Bioscience Announces Fourth Quarter and Full-Year 2024 Financial Results |
| 12 Mar 2025 | Pengumuman | Harvard Bioscience, Inc. to Participate in Two Investor Conferences in March 2025 |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |